Literature DB >> 1364823

Selective and competitive antagonism by suramin of ATP-stimulated catecholamine-secretion from PC12 phaeochromocytoma cells.

K Inoue1, K Nakazawa, M Ohara-Imaizumi, T Obama, K Fujimori, A Takanaka.   

Abstract

1. Suramin, a putative P2-antagonist, (10 to 300 microM) inhibited the adenosine 5'-triphosphate (ATP)-stimulated secretion of [3H]-noradrenaline or endogenous dopamine from phaeochromocytoma PC12 cells in a concentration-dependent manner. Suramin (300 microM) did not affect the dopamine-secretion stimulated by high K+ or nicotine. 2. Suramin shifted the concentration-response curve for ATP to the right. The antagonism was competitive with a pA2 value of 4.52. 3. ATP also stimulated an increase in intracellular Ca2+ concentration as determined by fura-2 methods. Suramin antagonized this effect over the same concentration range that antagonized the ATP-stimulated catecholamine secretion. 4. These results suggest that suramin can be used as a selective and competitive antagonist of ATP in experiments concerning mechanisms of catecholamine-secretion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1364823      PMCID: PMC1917940          DOI: 10.1111/j.1476-5381.1991.tb12216.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  An ATP-activated conductance in pheochromocytoma cells and its suppression by extracellular calcium.

Authors:  K Nakazawa; K Fujimori; A Takanaka; K Inoue
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

Review 2.  ATP-activated channels in excitable cells.

Authors:  B P Bean; D D Friel
Journal:  Ion Channels       Date:  1990

3.  The inhibitory action of suramin on the P2-purinoceptor response in smooth muscle cells of guinea-pig taenia caeci.

Authors:  A den Hertog; A Nelemans; J Van den Akker
Journal:  Eur J Pharmacol       Date:  1989-08-03       Impact factor: 4.432

4.  Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.

Authors:  P M Dunn; A G Blakeley
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

Review 5.  Extracellular ATP: effects, sources and fate.

Authors:  J L Gordon
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

6.  Muscarinic stimulation of calcium influx and norepinephrine release in PC12 cells.

Authors:  K Inoue; J G Kenimer
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

7.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

8.  A dual function for adenosine 5'-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent.

Authors:  G Burnstock; C Kennedy
Journal:  Circ Res       Date:  1986-03       Impact factor: 17.367

9.  Extracellular adenosine 5'-triphosphate-evoked norepinephrine secretion not relating to voltage-gated Ca channels in pheochromocytoma PC12 cells.

Authors:  K Inoue; K Nakazawa; K Fujimori; A Takanaka
Journal:  Neurosci Lett       Date:  1989-12-04       Impact factor: 3.046

10.  Reversible and selective antagonism by suramin of ATP-activated inward current in PC12 phaeochromocytoma cells.

Authors:  K Nakazawa; K Fujimori; A Takanaka; K Inoue
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

  10 in total
  10 in total

1.  Inhibition of adenylyl cyclase by neuronal P2Y receptors.

Authors:  Ursula Unterberger; Eugenia Moskvina; Thomas Scholze; Michael Freissmuth; Stefan Boehm
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.

Authors:  S M Hourani; D A Hall; C J Nieman
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

3.  A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.

Authors:  C Ho; J Hicks; M W Salter
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 4.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

5.  Effects of ATP antagonists on purinoceptor-operated inward currents in rat phaeochromocytoma cells.

Authors:  K Nakazawa; K Inoue; K Fujimori; A Takanaka
Journal:  Pflugers Arch       Date:  1991-04       Impact factor: 3.657

6.  Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors.

Authors:  K Kurz; I von Kügelgen; K Starke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Suramin and reactive blue 2 are antagonists for a newly identified purinoceptor on rat megakaryocyte.

Authors:  H Uneyama; C Uneyama; S Ebihara; N Akaike
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

8.  Effects of ATP and UTP in pheochromocytoma PC12 cells: evidence for the presence of three P2 receptors, only one of which subserves stimulation of norepinephrine release.

Authors:  B Nikodijevic; Y Sei; Y Shin; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1994-02       Impact factor: 5.046

9.  Inhibition by suramin and reactive blue 2 of GABA and glutamate receptor channels in rat hippocampal neurons.

Authors:  K Nakazawa; K Inoue; K Ito; S Koizumi; K Inoue
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-02       Impact factor: 3.000

10.  The effects of Suramin on Ca2+ activated force and sarcoplasmic reticulum Ca2+ release in skinned fast-twitch skeletal muscle fibers of the rat.

Authors:  Dane W Williams; Dimitrie George Stephenson; Giuseppe S Posterino
Journal:  Physiol Rep       Date:  2017-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.